{"id":173075,"date":"2026-07-27T11:27:07","date_gmt":"2026-07-27T11:27:07","guid":{"rendered":"https:\/\/www.m3globalresearch.com\/blog\/?p=173075"},"modified":"2026-07-27T13:19:35","modified_gmt":"2026-07-27T13:19:35","slug":"oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial","status":"publish","type":"post","link":"https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/","title":{"rendered":"Oral Vaccine Shows Promising Protection Against Shigellosis in Clinical Trial"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"173075\" class=\"elementor elementor-173075\" data-elementor-settings=\"{&quot;ha_cmc_init_switcher&quot;:&quot;no&quot;}\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7b2c08d e-con e-atomic-element e-flexbox-base e-d693f31 \" data-id=\"7b2c08d\" data-element_type=\"e-flexbox\" data-e-type=\"e-flexbox\" data-interaction-id=\"7b2c08d\" data-e-type=\"e-flexbox\" data-id=\"7b2c08d\">\n    \t\t<div class=\"elementor-element elementor-element-b12c334 elementor-widget elementor-widget-text-editor\" data-id=\"b12c334\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>An experimental oral vaccine significantly reduced shigellosis infections in a Phase 2 clinical trial, offering hope for preventing a bacterial disease that causes millions of infections worldwide each year. The findings were published in The Lancet Infectious Diseases Researchers tested a vaccine called WRSs2, which contains a weakened strain of Shigella sonnei bacteria. In the trial, 108 US adults aged 18 to 49 with little pre-existing immunity received either two doses of the vaccine or a placebo, administered 28 days apart.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bcdb794 elementor-widget elementor-widget-text-editor\" data-id=\"bcdb794\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Nearly a month after vaccination, participants received a controlled oral dose of live, full-strength S. sonnei bacteria in a closely monitored inpatient setting. Only 3 of 34 vaccinated participants developed shigellosis, compared with 21 of 26 placebo recipients. Just 3% of vaccinated participants developed severe symptoms such as high fever or excessive diarrhoea, compared with 69% of those receiving placebo.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-65630bd elementor-widget elementor-widget-text-editor\" data-id=\"65630bd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Study co-author Nadine Rouphael, a vaccinologist at Emory University, noted the protection level exceeds what has generally been reported in previous Shigella vaccine studies. Currently, no approved vaccines exist for shigellosis.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d9f354e elementor-widget elementor-widget-text-editor\" data-id=\"d9f354e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Shigellosis spreads through contaminated food, water, surfaces, or sexual contact. In the United States, the bacterium causes an estimated 450,000 infections annually, with approximately 242,000 resistant to at least one antimicrobial drug. Worldwide, infections exceed 80 million yearly, with children under five facing the greatest risk.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ff0552f elementor-widget elementor-widget-text-editor\" data-id=\"ff0552f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Experts noted limitations: the vaccine targeted S. sonnei, the dominant species in the United States, whilst S. flexneri predominates globally. Further trials in young children in low- and middle-income countries, who bear the greatest disease burden, will be needed. Regulatory approval could take three to six years.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bb5aaf1 elementor-widget elementor-widget-text-editor\" data-id=\"bb5aaf1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Source: Science News \/ The Lancet Infectious Diseases (2026)<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\n<\/div>\n\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Phase 2 trial: oral vaccine against Shigella sonnei reduced shigellosis infections, offering hope for future prevention.<\/p>\n","protected":false},"author":11,"featured_media":173112,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_eb_attr":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[3200],"tags":[],"class_list":["post-173075","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-medical-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.9 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Oral Vaccine Shows Promising Protection Against Shigellosis in Clinical Trial<\/title>\n<meta name=\"description\" content=\"Phase 2 trial: Oral vaccine against Shigella sonnei reduced shigellosis infections, offering hope for future prevention.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oral Vaccine Shows Promising Protection Against Shigellosis in Clinical Trial\" \/>\n<meta property=\"og:description\" content=\"Phase 2 trial: Oral vaccine against Shigella sonnei reduced shigellosis infections, offering hope for future prevention.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"M3 Global Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/en-gb.facebook.com\/M3GlobalResearch\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-27T11:27:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-27T13:19:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/07\/Shigellosis-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Admin B.\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"TAVR matches open-heart surgery durability in low-risk patients, as PARTNER 3 trial seven-year data confirm lasting valve performance.\" \/>\n<meta name=\"twitter:creator\" content=\"@M3GR_Community\" \/>\n<meta name=\"twitter:site\" content=\"@M3GR_Community\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Admin B.\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\\\/\"},\"author\":{\"name\":\"Admin B.\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/person\\\/2694d930280885a6f8adfd3c7090c10b\"},\"headline\":\"Oral Vaccine Shows Promising Protection Against Shigellosis in Clinical Trial\",\"datePublished\":\"2026-07-27T11:27:07+00:00\",\"dateModified\":\"2026-07-27T13:19:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\\\/\"},\"wordCount\":268,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Shigellosis-scaled.jpeg?fit=2560%2C1440&ssl=1\",\"articleSection\":[\"Latest Medical News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\\\/#respond\"]}]},{\"@type\":[\"WebPage\",\"MedicalWebPage\"],\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\\\/\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\\\/\",\"name\":\"Oral Vaccine Shows Promising Protection Against Shigellosis in Clinical Trial\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Shigellosis-scaled.jpeg?fit=2560%2C1440&ssl=1\",\"datePublished\":\"2026-07-27T11:27:07+00:00\",\"dateModified\":\"2026-07-27T13:19:35+00:00\",\"description\":\"Phase 2 trial: Oral vaccine against Shigella sonnei reduced shigellosis infections, offering hope for future prevention.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Shigellosis-scaled.jpeg?fit=2560%2C1440&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Shigellosis-scaled.jpeg?fit=2560%2C1440&ssl=1\",\"width\":2560,\"height\":1440,\"caption\":\"Phase 2 trial: oral vaccine against shigella sonnei reduced shigellosis infections, offering hope for future prevention.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oral Vaccine Shows Promising Protection Against Shigellosis in Clinical Trial\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/\",\"name\":\"M3 Global Research\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#organization\",\"name\":\"M3 Global Research\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":null,\"contentUrl\":null,\"width\":null,\"height\":null,\"caption\":\"M3 Global Research\"},\"image\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/en-gb.facebook.com\\\/M3GlobalResearch\\\/\",\"https:\\\/\\\/x.com\\\/M3GR_Community\",\"https:\\\/\\\/www.instagram.com\\\/m3globalresearch\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/10557915\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/person\\\/2694d930280885a6f8adfd3c7090c10b\",\"name\":\"Admin B.\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5f811bebef837ff0367d28aa777df5c8b43795cab6f9ff385cce49abb4e04a6f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5f811bebef837ff0367d28aa777df5c8b43795cab6f9ff385cce49abb4e04a6f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5f811bebef837ff0367d28aa777df5c8b43795cab6f9ff385cce49abb4e04a6f?s=96&d=mm&r=g\",\"caption\":\"Admin B.\"},\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/author\\\/admin-b\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Oral Vaccine Shows Promising Protection Against Shigellosis in Clinical Trial","description":"Phase 2 trial: Oral vaccine against Shigella sonnei reduced shigellosis infections, offering hope for future prevention.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/","og_locale":"en_US","og_type":"article","og_title":"Oral Vaccine Shows Promising Protection Against Shigellosis in Clinical Trial","og_description":"Phase 2 trial: Oral vaccine against Shigella sonnei reduced shigellosis infections, offering hope for future prevention.","og_url":"https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/","og_site_name":"M3 Global Research","article_publisher":"https:\/\/en-gb.facebook.com\/M3GlobalResearch\/","article_published_time":"2026-07-27T11:27:07+00:00","article_modified_time":"2026-07-27T13:19:35+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/07\/Shigellosis-scaled.jpeg","type":"image\/jpeg"}],"author":"Admin B.","twitter_card":"summary_large_image","twitter_description":"TAVR matches open-heart surgery durability in low-risk patients, as PARTNER 3 trial seven-year data confirm lasting valve performance.","twitter_creator":"@M3GR_Community","twitter_site":"@M3GR_Community","twitter_misc":{"Written by":"Admin B.","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/#article","isPartOf":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/"},"author":{"name":"Admin B.","@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/person\/2694d930280885a6f8adfd3c7090c10b"},"headline":"Oral Vaccine Shows Promising Protection Against Shigellosis in Clinical Trial","datePublished":"2026-07-27T11:27:07+00:00","dateModified":"2026-07-27T13:19:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/"},"wordCount":268,"commentCount":0,"publisher":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/07\/Shigellosis-scaled.jpeg?fit=2560%2C1440&ssl=1","articleSection":["Latest Medical News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/#respond"]}]},{"@type":["WebPage","MedicalWebPage"],"@id":"https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/","url":"https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/","name":"Oral Vaccine Shows Promising Protection Against Shigellosis in Clinical Trial","isPartOf":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/#primaryimage"},"image":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/07\/Shigellosis-scaled.jpeg?fit=2560%2C1440&ssl=1","datePublished":"2026-07-27T11:27:07+00:00","dateModified":"2026-07-27T13:19:35+00:00","description":"Phase 2 trial: Oral vaccine against Shigella sonnei reduced shigellosis infections, offering hope for future prevention.","breadcrumb":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/#primaryimage","url":"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/07\/Shigellosis-scaled.jpeg?fit=2560%2C1440&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/07\/Shigellosis-scaled.jpeg?fit=2560%2C1440&ssl=1","width":2560,"height":1440,"caption":"Phase 2 trial: oral vaccine against shigella sonnei reduced shigellosis infections, offering hope for future prevention."},{"@type":"BreadcrumbList","@id":"https:\/\/www.m3globalresearch.com\/blog\/oral-vaccine-shows-promising-protection-against-shigellosis-clinical-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.m3globalresearch.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Oral Vaccine Shows Promising Protection Against Shigellosis in Clinical Trial"}]},{"@type":"WebSite","@id":"https:\/\/www.m3globalresearch.com\/blog\/#website","url":"https:\/\/www.m3globalresearch.com\/blog\/","name":"M3 Global Research","description":"","publisher":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.m3globalresearch.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.m3globalresearch.com\/blog\/#organization","name":"M3 Global Research","url":"https:\/\/www.m3globalresearch.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/logo\/image\/","url":null,"contentUrl":null,"width":null,"height":null,"caption":"M3 Global Research"},"image":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/en-gb.facebook.com\/M3GlobalResearch\/","https:\/\/x.com\/M3GR_Community","https:\/\/www.instagram.com\/m3globalresearch","https:\/\/www.linkedin.com\/company\/10557915"]},{"@type":"Person","@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/person\/2694d930280885a6f8adfd3c7090c10b","name":"Admin B.","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/5f811bebef837ff0367d28aa777df5c8b43795cab6f9ff385cce49abb4e04a6f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/5f811bebef837ff0367d28aa777df5c8b43795cab6f9ff385cce49abb4e04a6f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5f811bebef837ff0367d28aa777df5c8b43795cab6f9ff385cce49abb4e04a6f?s=96&d=mm&r=g","caption":"Admin B."},"url":"https:\/\/www.m3globalresearch.com\/blog\/author\/admin-b\/"}]}},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/07\/Shigellosis-scaled.jpeg?fit=2560%2C1440&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts\/173075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/comments?post=173075"}],"version-history":[{"count":19,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts\/173075\/revisions"}],"predecessor-version":[{"id":173167,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts\/173075\/revisions\/173167"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/media\/173112"}],"wp:attachment":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/media?parent=173075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/categories?post=173075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/tags?post=173075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}